RGC (Regencell Bioscience Holdings) Total Liabilities: $1.79 Mil (As of Dec. 2025)


RGC Regencell Bioscience Holdings Ltd RGC
34 GF Score
Price $6.36
! 2 Warning Signs
View Full Analysis

What is Regencell Bioscience Holdings Total Liabilities?

Regencell Bioscience Holdings RGC -13.25% 34 Total Liabilities is $1.79 Mil as of Dec. 2025. GuruFocus rates RGC with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

Regencell Bioscience Holdings's Total Liabilities for the quarter that ended in Dec. 2025 was $1.79 Mil.

Regencell Bioscience Holdings's quarterly Total Liabilities increased from Dec. 2024 ($0.76 Mil) to Jun. 2025 ($0.90 Mil) and increased from Jun. 2025 ($0.90 Mil) to Dec. 2025 ($1.79 Mil).

Regencell Bioscience Holdings's annual Total Liabilities declined from Jun. 2023 ($0.63 Mil) to Jun. 2024 ($0.22 Mil) but then increased from Jun. 2024 ($0.22 Mil) to Jun. 2025 ($0.90 Mil).

Regencell Bioscience Holdings Total Liabilities Historical Data

* Premium members only.

The historical data trend for Regencell Bioscience Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regencell Bioscience Holdings Total Liabilities Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Liabilities
Get a 7-Day Free Trial 4.34 0.94 0.63 0.22 0.90

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.22 0.76 0.90 1.79
RGC
34GF Score
Regencell Bioscience Holdings Ltd RGC
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regencell Bioscience Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Regencell Bioscience Holdings's Total Liabilities for the fiscal year that ended in Jun. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.664+(0.232+-0.001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.90

Total Liabilities=Total Assets (A: Jun. 2025 )-Total Equity (A: Jun. 2025 )
=5.756-4.86
=0.90

Regencell Bioscience Holdings's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0+(0+1.794
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.79

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=3.013-1.219
=1.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $1.79 Mil mean?
Regencell Bioscience Holdings (RGC) has a Total Liabilities of $1.79 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Regencell Bioscience Holdings and its competitors.
Is Regencell Bioscience Holdings' Total Liabilities too high?
Regencell Bioscience Holdings' current Total Liabilities is $1.79 Mil. Overall, Regencell Bioscience Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Regencell Bioscience Holdings' Total Liabilities compare to ELAN and NBIX?
Regencell Bioscience Holdings' Total Liabilities of $1.79 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Regencell Bioscience Holdings and its competitors. Regencell Bioscience Holdings's current Total Liabilities is $1.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regencell Bioscience Holdings stock overvalued right now?
Regencell Bioscience Holdings (RGC) has a current Total Liabilities of $1.79 Mil. The current Total Liabilities is $1.79 Mil. Regencell Bioscience Holdings' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Regencell Bioscience Holdings (RGC), the current Total Liabilities is $1.79 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regencell Bioscience Holdings Business Description

Address 29 Leighton Road, 9th Floor, Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
34GF Score

Get the complete analysis for RGC

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.36
Price